Related references
Note: Only part of the references are listed.Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients
Marialaura Del Basso De Caro et al.
NEUROSURGICAL REVIEW (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Clinical Impact of the Current WHO Classification of Pituitary Adenomas
W. Saeger et al.
ENDOCRINE PATHOLOGY (2016)
Predictors of aggressive clinical phenotype among immunohistochemically confirmed atypical adenomas
Hasan A. Zaidi et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2016)
Atypical pituitary adenomas: 10 years of experience in a reference centre in Portugal
F. Tortosa et al.
NEUROLOGIA (2016)
The Predictive Value of Pathologic Features in Pituitary Adenoma and Correlation with Pituitary Adenoma Recurrence
Jee Soon Kim et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2016)
Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis
Sabrina Chiloiro et al.
NEUROENDOCRINOLOGY (2015)
Histological criteria for atypical pituitary adenomas - data from the German pituitary adenoma registry suggests modifications
Christian P. Miermeister et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)
Management of aggressive pituitary adenomas and pituitary carcinomas
Anthony Heaney
JOURNAL OF NEURO-ONCOLOGY (2014)
Aggressive pituitary adenomas-diagnosis and emerging treatments
Antonio Di Ieva et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Atypical pituitary adenomas: incidence, clinical characteristics, and implications Clinical article
Gabriel Zada et al.
JOURNAL OF NEUROSURGERY (2011)
Preoperative MRI Evaluation of Pituitary Macroadenoma: Imaging Features Predictive of Successful Transsphenoidal Surgery
Jerrold L. Boxerman et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
KI-67 IN PITUITARY NEOPLASMS: A REVIEW-PART I
Fateme Salehi et al.
NEUROSURGERY (2009)
Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas
Roger Gejman et al.
HUMAN PATHOLOGY (2008)
Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas
A. Fusco et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors
Anne Wierinckx et al.
ENDOCRINE-RELATED CANCER (2007)
Pathohistological classification of pituitary tumors:: 10 years of experience with the German Pituitary Tumor Registry
Wolfgang Saeger et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Pathobiology of pituitary adenomas and carcinomas
Bernd W. Scheithauer et al.
NEUROSURGERY (2006)
Pituitary macroadenomas: Preoperative evaluation of consistency with diffusion-weighted MR imaging - Initial experience
A Pierallini et al.
RADIOLOGY (2006)
Predictive markers of pituitary adenoma behavior
George Kontogeorgos
NEUROENDOCRINOLOGY (2006)
Expression of Ki-67 antigen in nonfunctioning pituitary adenomas:: correlation with growth velocity and invasiveness
J Honegger et al.
JOURNAL OF NEUROSURGERY (2003)
P53 and MIB-1 immunohistochemistry as predictors of the clinical behavior of nonfunctioning pituitary adenomas
SJ Hentschel et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2003)
A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas
ML Jaffrain-Rea et al.
ENDOCRINE-RELATED CANCER (2002)
Mdm2 and the p53 pathway in human pituitary adenomas
M Suliman et al.
CLINICAL ENDOCRINOLOGY (2001)
Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors - Comparison between micro- and macroadenomas
M Losa et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)